Sign inGet started

DiFabio Andrea

Insider CIK 1692506 · XENE Chief Legal Officer · BIVV EVP, Chief Legal Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
XENE Xenon Pharmaceuticals Inc. S Sale2026-03-132026-03-131,342$55.23 $74.1K7,301SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise deriv2026-03-122026-03-133,750— $011,250SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise2026-03-122026-03-133,750— $08,643SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2026-03-102026-03-112,607$60.11 $156.7K4,893SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2026-03-092026-03-117,500— $07,500SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise deriv2026-03-092026-03-117,500— $00SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise2026-03-092026-03-117,500— $07,500SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2026-01-092026-01-0980,000— $080,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2026-01-092026-01-0915,000— $015,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2025-03-122025-03-1380,000— $080,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2025-03-122025-03-1315,000— $015,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2024-03-112024-03-12100,000— $0100,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2023-03-102023-03-1445,000— $045,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2022-11-072022-11-09135,000— $0135,000SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-087,489— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0831,818— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0829,797— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0829,797— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0859,595— $00SEC↗
BIVV Bioverativ Inc. D To issuer2018-03-082018-03-0830,600— $00SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-232018-02-26917$104.74 $96.0K30,411SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-222018-02-262,011$104.30 $209.7K31,328SEC↗
BIVV Bioverativ Inc. M Exercise deriv2018-02-142018-02-153,744— $07,489SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-142018-02-151,136$103.52 $117.6K33,339SEC↗
BIVV Bioverativ Inc. M Exercise2018-02-142018-02-153,744— $034,475SEC↗
BIVV Bioverativ Inc. A Award deriv2018-01-312018-02-0231,818— $031,818SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-11-022017-11-03636$53.65 $34.1K30,731SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02285$49.56 $14.1K32,454SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02918$47.76 $43.8K31,536SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02718$43.42 $31.2K30,818SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02532$43.42 $23.1K32,739SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-021,191$47.76 $56.9K33,271SEC↗
BIVV Bioverativ Inc. A Award2017-02-282017-03-0235,019— $035,985SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-021,155$43.42 $50.2K34,830SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02368$49.56 $18.2K34,462SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1629,744— $029,744SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1659,488— $059,488SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1611,233— $011,233SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1629,744— $029,744SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2729,797— $029,797SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2759,595— $059,595SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2729,797— $029,797SEC↗